When you're living with ALS, every move matters
RADICAVA® (edaravone) is a treatment option for amyotrophic lateral sclerosis (ALS). In a clinical trial, RADICAVA® was shown to slow the decline of physical function.a
aAs measured by total score on the ALS Functional Rating Scale–Revised (ALSFRS-R) in a 24-week study of 137 participants. Individual results may vary.